Business Context and Reporting Period
Company: ARGENX SE
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of June 2022
Date of Filing: June 27, 2022
Principal Executive Offices: Willemstraat 5, 4811 AH, Breda, the Netherlands
This filing serves as a Current Report incorporating by reference a press release issued by the Company on June 24, 2022 (Exhibit 99.1). The information is also incorporated into the Company's Registration Statements on Forms F-3 and S-8.
Financial Metrics
The filing text does not provide specific financial data, including revenue, profit, cash flow, margins, debt, or liquidity metrics. The document acts solely as a vehicle to distribute the attached press release.
Material Changes
The filing text does not explicitly detail material changes versus prior periods. It references a press release dated June 24, 2022, which contains the substantive information regarding any updates or changes, but the text of that release is not included in the provided input.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumed to be contained within the attached Exhibit 99.1 (Press Release), the content of which is not provided in the source text.
Key Facts for Investor Verification
- Verify the content of the press release dated June 24, 2022 (Exhibit 99.1), as this filing incorporates it by reference but does not reproduce the text.
- Confirm the specific operational or clinical updates announced in the June 24 press release, as no such details are present in the Form 6-K body.
- Note that this filing updates Registration Statements on Forms F-3 (File No. 333-258251) and S-8 (File Nos. 333-225375 and 333-258253).